India's Lupin gets U.S. nod for schizophrenia capsules
Home page > News

India's Lupin gets U.S. nod for schizophrenia capsules

www.reuters.com   | 05.03.2012.

(Reuters) - India's Lupin Ltd has received the U.S. Food and Drug Administration's approval for the generic version of Geodon capsules used to treat schizophrenia, the drugmaker said on Monday.
br />

The Geodon brand, owned by Pfizer Inc, had annual sales of $1.35 billion in the United States in 2011, Lupin said in a statement.

(Reporting by Kaustubh Kulkarni in MUMBAI; Editing by Rajesh Pandathil)


Comments (0) Add Your comment Add news < Previous news Next news >






  Add your news >>>